25-year trends of incidence and mortality from liver cancer and viral hepatitis in novosibirsk
Vol. 62 No. 1 (2016), Articles
Vol. 62 No. 1 (2016)

25-year trends of incidence and mortality from liver cancer and viral hepatitis in novosibirsk

Articles
https://doi.org/10.37469/0507-3758-2016-62-1-57-62
Published 15.12.2016
Research Institute of Internal and Preventive Medicine
Research Institute of Internal and Preventive Medicine
Research Institute of Internal and Preventive Medicine; Novosibirsk State Medical University
Novosibirsk State Medical University
Research Institute of Internal and Preventive Medicine
PDF (Русский)

Keywords

incidence
primary liver cancer
mortality
prevention
cancer registry
viral hepatitis

How to Cite

, , , , & . (2016). 25-year trends of incidence and mortality from liver cancer and viral hepatitis in novosibirsk. Voprosy Onkologii, 62(1), 57–62. https://doi.org/10.37469/0507-3758-2016-62-1-57-62
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

The article presents data of Cancer Registry in Novosibirsk for the period 1988-2012 concerning primary liver cancer. Over the period studied the incidence and mortality have declined significantly (2,5 and 2,1 times, respectively). Both figures fall in line for men and women being generally twice as high in men. The long-term trends of main etiologic risk factor for liver cancer (prevalence of hepatitis viruses B and C in the population) are shown. The issues of screening and prevention are discussed.
https://doi.org/10.37469/0507-3758-2016-62-1-57-62
PDF (Русский)

References

Бугаева ТТ., Алексеева М.Н. Иванов П.М. Хронические вирусные гепатиты как основные факторы риска развития гепатоцеллюлярной карциномы в Якутии // Сиб. мед. журнал.- 2007.- № 2 (Приложение) С. 47-49.

Злокачественные новообразования в России в 2011 году (заболеваемость и смертность) / Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой // М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России. - 2013. - 289 с.

Писарева Л.Ф., Чойнзонов Е.Л., Жуйкова Л.Д. и др. Анализ контингентов посмертно учтённых онкологических больных в Томской области в 2007-2011 гг. // Профилактическая медицина. - 2013.- № 1. - С 3439.

Bosch F.X, Ribes J., Daz M., Cl ries R. Primary liver cancer: worldwide incidence and trends // Gastroenterology. - 2004. - Vol. 127. - Suppl 1. - P. S5-S16.

Bosetti C., Turati F., La Vecchia C. Hepatocellular carcinoma epidemiology // Best Pract Res Clin Gastroenterol. - 2014. - Vol. 28. - P. 753-770.

Chang M., You S., Chen C. et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study // J Natl Cancer Inst. - 2009. - Vol. 101. - P 1348-1355.

Chang R.T., Davis G.L., Masur H. et al. Hepatitis C Guidance: AASL-IDSA recommendations for testing, managing and treating adults infected with hepatitis C virus // Hepatology. - 2015. - Vol. 61. - P 1-78.

Ferlay J., Shin H.R., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // Int J Cancer. - 2010. - Vol. 127. - P. 2893-2917.

Freeman A., Dore G., Law M. et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection // Hepatology. - 2001. - Vol. 34. - P 809-816.

Hsu C.S., Huang C.J., Kao J.H. et al. Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients // PLoS One. - 2013. - Vol. 23. - № 8 (7). - P e70458.

Lafaro K.J., Demirjian A.N., Pawlik T.M. Epidemiology of hepatocellular carcinoma // Surg Oncol Clin N Am. - 2015. - Vol. 24. - P. 1-17.

Malek N.P, Schmidt S., Huber P et al. Clinical practice guideline: The diagnosis and treatment of hepatocellar carcinoma // Dtsch Arztebl Int. - 2014. - Vol. 111. - Р. 101-106.

Ringelhan M., O’Connor T., Protzer U., Heikenwalder M. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets // J Pathol. - 2015. - Vol. 235. - P. 355-367.

Singal A.G., Conjeevaram H.S., Volk M.L. et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis // Cancer Epidemiol Biomarkers Prev. - 2012. - Vol. 21. - P. 793-799.

Sinn D.H., Gwak G.Y Cho J. et al. Comparison of clinical manifestations and outcomes between hepatitis B virus-and hepatitis C virus-related hepatocellular carcinoma: Analysis of a nationwide cohort // PLoS ONE. - 2014. - Vol. 9 (11). - P. e112184. doi:10.1371/journal. pone.0112184.

Smith B.D., Beckett G.A., Yartel A. et al. Рrevious exposure to HCV among persons born during 1945-1965. Рrevalence and predictors, United States, 1999-2008 // Am J Public Health. - 2014. - Vol. 104. - P. 474-481.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...